As recently updated by PTCB.org, there are six core sections of the Patient Safety and Quality Assurance knowledge domain. Below, we have put together the key sections as well as examples of the kind of detail that gets tested:
| Section | Topic | Examples / Description |
| 3.1 | High-alert/risk medications and look-alike/sound-alike (LASA) medications | Covers identification and management of high-alert drugs (e.g. insulin, anticoagulants, opioids, chemotherapy) and LASA medications (e.g., hydrOXYzine vs. hydrALAZINE). Emphasizes strategies like separate storage, color coding, and tall man lettering to minimize confusion and prevent errors. |
| 3.2 | Error prevention strategies | Focuses on techniques to reduce medication errors — using Tall Man lettering, avoiding error-prone abbreviations, proper leading and trailing zero usage, employing barcoding systems, and organizing inventory to reduce mix-ups. Also includes verifying prescriptions with patients and prescribers before dispensing. |
| 3.3 | Issues that require pharmacist intervention | Situations requiring direct pharmacist action, including drug utilization reviews (DURs), identifying adverse drug events (ADEs), recommending appropriate OTC products, managing therapeutic substitutions, monitoring medication adherence, addressing allergies or drug interactions, and providing post-immunization care. |
| 3.4 | Event reporting procedures | Covers protocols for reporting and analyzing errors or adverse events. Includes systems such as MedWatch, VAERS, CQI, and root-cause analysis (RCA). Also addresses how to document near misses and implement continuous quality improvement (CQI) processes to prevent recurrence. |
| 3.5 | Types of prescription errors | Identifies different error types such as wrong dose, incorrect quantity, wrong patient, wrong drug, or wrong route of administration. Emphasizes double-checking, using barcode verification, and maintaining clear communication among pharmacy staff to detect and prevent these errors. |
| 3.6 | Infection prevention procedures and cleaning standards | Focuses on maintaining clean and sterile work areas, including hand hygiene, proper use of personal protective equipment (PPE), and regular cleaning of counting trays, countertops, and equipment. Ensures compliance with infection control protocols to maintain a safe pharmacy environment. |
Below you can find sample patient safety and quality assurance questions that reflect the style and standard of questions tested on the PTCB exam.
Insulin is classified as a high-alert medication because dosing errors can result in severe hypoglycemia or hyperglycemia, both of which can be life-threatening.
High-alert medications require extra precautions during prescribing, dispensing, and administration.
Amoxicillin, metformin, and loratadine are not generally classified as high-alert medications.
Hydralazine (used for hypertension) and hydroxyzine (an antihistamine) have similar names, making them prone to selection errors.
This is an example of a look-alike/sound-alike medication error.
It is not a duplication, interaction, or adverse reaction — it is a name confusion issue that can occur during order entry.
Sertraline and fluoxetine are both SSRI antidepressants.
Two medications from the same therapeutic class may represent duplication and increase the risk of adverse effects (e.g. serotonin syndrome).
As this is a potential safety issue, it requires pharmacist intervention.
Repeated early refill requests may indicate overuse, underuse, loss of medication, or confusion about dosing.
Monitoring adherence concerns is a pharmacist responsibility, but technicians must recognize refill patterns that require review before processing.
Difficulty breathing after vaccination may indicate anaphylaxis, a medical emergency.
Post-immunization adverse events require immediate pharmacist assessment and emergency protocol activation.
MedWatch is the FDA’s Safety Information and Adverse Event Reporting Program used to report serious adverse drug reactions, product quality issues, and medication errors involving FDA-regulated products.
VAERS is specific to vaccines.
PDMP tracks controlled substance prescriptions.
DEA Form 106 is used to report theft or significant loss of controlled substances.
Near misses must be documented as part of a pharmacy’s Continuous Quality Improvement (CQI) program.
Root-cause analysis (RCA) helps identify system-based factors that contributed to the error (e.g. workflow issues, labeling similarities) so corrective measures can be implemented.
Even though no harm occurred, analyzing near misses prevents future incidents.







Work your way through study notes, cheat sheets, and exam-like practice questions that detail all the essential facts technicians need to know to succeed at the patient safety & quality assurance knowledge domain.